Advanced Nanotheranostics of CRISPR/Cas for Viral Hepatitis and Hepatocellular Carcinoma

Abstract Liver disease, particularly viral hepatitis and hepatocellular carcinoma (HCC), is a global healthcare burden and leads to more than 2 million deaths per year worldwide. Despite some success in diagnosis and vaccine development, there are still unmet needs to improve diagnostics and therape...

Full description

Bibliographic Details
Main Authors: Huimin Kong, Enguo Ju, Ke Yi, Weiguo Xu, Yeh‐Hsing Lao, Du Cheng, Qi Zhang, Yu Tao, Mingqiang Li, Jianxun Ding
Format: Article
Language:English
Published: Wiley 2021-12-01
Series:Advanced Science
Subjects:
Online Access:https://doi.org/10.1002/advs.202102051